|
# # # # Without a shadow of doubt, one of the most popular topics that readers search for on this website is ‘mannitol’. It is a widely used sweetner that became very popular in the Parkinson’s community after a 2013 research report presented compelling results that this molecule exhibited robust anti-aggregation properties on the Parkinson’s-associated protein alpha synuclein. Recently the results of a carefully designed clinical trial evaluating mannitol have been published. In today’s post, we will look at what mannitol is, review the previous research conducted on this agent in the context of Parkinson’s, and consider the results of the clinical trial. # # # # |
Source: History
During the forty years that the Israelites wandered the desert after leaving Egypt, they faced many hardships, most notably a scarcity of food. To resolve this particular issue, God kindly provided the Israelites with “bread from heaven”.
According to the scriptures, it was a “fine, flake-like thing, fine as frost on the ground” and “It was like coriander seed, white, and the taste of it was like wafers made with honey” (Exodus, Chapter 16).
They called “manna”.
Hence the phrase: Like manna from heaven
More recently, a substance called manna, has been the focus of a lot of attention in the Parkinson’s community.
A group of Israeli researchers have been exploring the potential of the sweetener ‘Mannitol’ (also known as Manna sugar) in the context of Parkinson’s.
What is mannitol?
The Science of Parkinson's 